Free Trial
LON:GENF

Genflow Biosciences (GENF) Share Price, News & Analysis

GBX 1.80
0.00 (0.00%)
(As of 11/1/2024 ET)

About Genflow Biosciences Stock (LON:GENF)

Key Stats

Today's Range
1.75
1.84
50-Day Range
1.80
2.40
52-Week Range
1.32
3.41
Volume
18,633 shs
Average Volume
1.03 million shs
Market Capitalization
£6.29 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and GF-4001, a non-human pipeline anti-aging for veterinary use. Genflow Biosciences plc was incorporated in 2021 and is headquartered in London, the United Kingdom.

Receive GENF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter.

GENF Stock News Headlines

Genflow Biosciences PLC (GENF)
See More Headlines

GENF Stock Analysis - Frequently Asked Questions

Genflow Biosciences' stock was trading at GBX 1.43 at the beginning of 2024. Since then, GENF shares have increased by 26.3% and is now trading at GBX 1.80.
View the best growth stocks for 2024 here
.

Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), Medical Properties Trust (MPW), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
£-1,530,000.00
Net Margins
-256.07%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
£6.29 million
Optionable
Not Optionable
Beta
2.37
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (LON:GENF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners